Male Contraceptive Initiative’s 2025 Annual Report
Introduction
Welcome to the MCI 2025 Annual Report!
The year 2025 marked a transformative period for the Male Contraceptive Initiative. Throughout the year, we witnessed an expansion of momentum and financial backing across our ecosystem, drawing together researchers, clinicians, advocates, and global stakeholders.
Reflecting our central theme, “Shared Progress,” this report honors our collective, and collaborative, journey. It underscores a fundamental conviction: expanding reproductive choices for men requires an interconnected community working in unison. We remain deeply grateful for the collective efforts that have bridged disciplines, disseminated crucial insights, and propelled the field forward.
Historically, male contraceptive science remained largely restricted to academic laboratories. While supporting rigorous basic science remains central to our purpose, driving meaningful progress demands a far broader framework. We have intentionally cultivated a robust, integrated ecosystem that connects academic investigators, biotechnology leaders, industry partners, and global health advocates. Within this report, we detail how these strategic alliances have accelerated scientific discovery, refined regulatory pathways, and advanced us toward a future defined by comprehensive contraceptive equity. Looking forward, cross-sector partnership remains our most vital instrument. Though complex obstacles persist, the dedication of our global community provides unwavering optimism as we navigate the journey ahead.
We encourage you to examine these achievements and discover how our joint endeavors are advancing research while fostering greater autonomy for individuals worldwide.
We are proud to highlight these key milestones and welcome you to explore the detailed updates below, capturing a year defined by joint impact and progress.
Showing Up Together for Reproductive Equity
MCI Executive Director Heather Vahdat's Annual Letter
Dear Friends, Colleagues, and Supporters,
In 2025, it was the year the male contraceptive field showed up in the same room. In April, hundreds of scientists, clinicians, funders, trainees, and advocates gathered in Durham for the National Contraception Meeting, and I saw what reproductive autonomy for all looks like when a community decides to work on it together.
The meeting was only one part of a year that also moved male contraception onto European regulators’ agenda, carried our conversations to partners in Argentina, Kenya, South Africa, and Zambia, and welcomed a record number of fellowship applicants. Behind each of those milestones is a team, a network of grantees, and donors who believe couples deserve more choices.
Thank you for being part of it. I am proud of what we built in 2025, and I am even more excited about what comes next.
With heartfelt gratitude,
Heather Vahdat, MPH
MCI Executive Director
MCI's Organizational Overview
Historically, the burden of family planning has fallen disproportionately on women. Today, men are left with limited options: condoms, which offer essential protection but carry an 87% typical-use effectiveness rate, or vasectomy, a permanent surgical intervention. This persistent gap has far-reaching implications, contributing to an estimated 121 million unintended pregnancies globally each year while placing disproportionate physical, emotional, and financial strains on women’s health, careers, and overall well-being.
Established in 2014, Male Contraceptive Initiative (MCI) is dedicated to addressing this fundamental disparity. We are committed to catalyzing the pipeline for novel, safe, non-hormonal, and reversible male methods. Our purpose extends well beyond expanding the method mix; we believe that expanding options for men fosters greater reproductive autonomy across all genders. By cultivating a more inclusive and equitable family planning ecosystem, we aim to ensure that shared decision-making and contraceptive equity become a universal reality.
MCI works through two key pillars of activity:
Driving Discovery & Expanding Choice
Catalyzing scientific breakthroughs requires more than capital alone. We cultivate an interconnected environment for investigators advancing novel male options, pairing strategic financial investments with targeted career building and mentorship. Through this comprehensive model, we empower transformative discoveries as they move from early discovery toward real-world application.
Building Knowledge, Shifting Perceptions
Advocacy serves as a foundational pillar of our overarching strategy. We strive to inform and engage global communities by curating clear, actionable educational materials, sparking meaningful public dialogue across dynamic digital channels, and organizing targeted community initiatives. Through these multifaceted efforts, we elevate awareness surrounding the critical role novel male family planning methods play in shaping a more equitable future.
Advancing novel male family planning choices extends far beyond developing new technologies; it serves as a powerful catalyst for bodily autonomy and global equity. To achieve this vision, we strive to:
- Significantly curb unplanned pregnancies: Unlocking expanded pathways toward intentional, self-determined parenthood.
- Elevate personal agency and alignment in method selection: Cultivating options that reflect individual lifestyles and values.
- Promote broader adoption and cultural resonance: Driving sustained engagement by framing contraception as a shared responsibility.
- Eliminate persistent disparities in healthcare availability: Addressing unmet needs across diverse global communities.
At Male Contraceptive Initiative, we remain steadfast in our commitment to fostering a world where reproductive autonomy is universally realized, empowering individuals everywhere to make confident choices with dignity.
MCI’s Theory of Change
2025 At-a-Glance
Throughout 2025, Male Contraceptive Initiative (MCI) served as a central catalyst for global reproductive equity, driving key developments across research, regulatory strategy, cross-sector partnership, and leadership development. Below is a detailed summary of key institutional milestones and measurable impacts achieved over the course of the year:
The 2025 National Contraception Meeting
From April 28 to May 1, 2025, MCI brought the male and female contraceptive fields together in Durham, NC, for a four-day meeting that mixed bench science, clinical development, global health, and advocacy. It was co-chaired by Drs. Lonny Levin, Jochen Buck, and Rahima Benhabbour, with MCI serving as host and organizer. The first and last days were MCI’s own contribution to the program, covering topics that earlier meetings had not included.
More than 330 people registered and 262 attended in person, with virtual links for each day. About 60 speakers presented across sessions on male and female targets, delivery systems, funding and consortia, and clinical and regulatory pathways, and roughly 59 trainee and investigator posters were on display. Keynote speaker Dr. Martin Matzuk opened the science program.
The meeting ran across the Carolina Theatre, Durham Convention Center, and Durham Arts Council. A separate On-Demand Contraception special topic meeting, held on April 24 ahead of the main event, brought about 35 experts together to begin defining what an on-demand male method should deliver.
What Attendees Said
In the exit survey, 97% of respondents were satisfied or very satisfied, every respondent rated the meeting very or extremely well organized, and 89% said the sessions met their expectations. The survey had 37 respondents, so these are best read as a snapshot. Attendees singled out the community, the venue, and the documentary screening, and described access to speakers at breaks and meals as a highlight.
Trainees and Community
Trainees presented posters and talks, were matched with mentors, and were recognized at the close of the meeting. The Youth Advisory Board presented a poster on its grant program, and its chair gave a trainee talk.
Thank You to Our Sponsors
The Gates Foundation sponsored the welcome reception. NC Biotech, YourChoice Therapeutics, Plan A / NEXT Life Sciences, Sacyl Pharmaceuticals, and Contraline also supported the meeting, along with a grant from the NC Biotechnology Center.
A Bold Commitment: The Global Contraceptive Development Fund
The meeting took place against the backdrop of dramatic US funding cuts in early 2025, including the dissolution of USAID, which put much of the field’s public funding at risk. MCI closed out the meeting by committing to establish the Global Contraceptive Development Fund (GCDF), a dedicated, durable source of funding for male contraceptive, non-hormonal female contraceptive, and multipurpose prevention technology (MPT) development. Since then, MCI has held planning meetings, studied comparable fund structures, and built out the case for the fund. Placeholder: Heather to add 2-3 specific accomplishments since the meeting. MCI is now ready to share the framework with the broader community for input. As we said from day one, MCI is shepherding the process, but the GCDF is designed to stand on its own two feet and to represent the needs of the male contraceptive, non-hormonal female contraceptive, and MPT communities.
Other Follow-up Commitments
MCI also committed to follow-up webinars, and the first, on sperm motility, was held on December 8, 2025 with a May meeting speaker, Dr. Aminata Toure of Universite Grenoble Alpes. Because many presentations included unpublished data, MCI chose not to post conference content online and shares only this high-level summary.
Funding
Maximizing the impact of every dollar and accelerating crucial research are the cornerstones of MCI’s investment philosophy for male contraceptives.
Our approach is twofold: we prioritize funding for innovative programs that directly drive the creation and testing of new methods, and we concurrently invest in building the human capital—the skilled researchers and passionate advocates—who are vital for the field’s sustained growth. This strategic allocation allows MCI to achieve critical short-term milestones while future-proofing the advancement of male contraception for generations to come.
The infographic below provides a clear overview of how our 2024 funding was strategically utilized to energize and expand the male contraception field:
Male Contraceptive Initiative’s 2025 Funding Activities
Research
MCI continued to fund non-hormonal, reversible male contraceptive development across the pipeline, from early discovery to early clinical work, and held to its expectation that funded work is published open access. The 2025 request for applications closed on August 1, and MCI’s Research Committee completed its review in the fall.
Fellows and Trainees
MCI’s 2025 fellowship program offered up to $360,000 in total, with awards of up to $70,000 for predoctoral and $130,000 for postdoctoral trainees. The program drew a record 26 applications, and 4 fellows were selected. Three summer trainees joined the team, two MPH students from UNC Gillings and one DrPH candidate from UC Berkeley.
Agility Grants and the Youth Advisory Board
Four Agility Grants, MCI’s rapid, small-scale awards, were made by March 2025. The Youth Advisory Board continued to fund an undergraduate each year for research or advocacy, and a paper supported by its grant, on interest in new methods among men who have had a vasectomy, was published this year.
Science that Moved the Field
- An MCI- and Gates-supported survey of thousands of men and their female partners across six countries, which found strong global support for shared contraceptive responsibility.
- A placebo-controlled trial of silodosin in 100 couples, published by independent investigators, reported 4 breakthrough pregnancies in the treatment arm over 3 months of dosing.
- A paper on soluble adenylyl cyclase (sAC) in sperm function.
Advocacy
In 2025 MCI’s advocacy work centered on the regulatory pathway for new male methods and on bringing the public into the conversation.
A Regulatory Milestone
MCI’s Regulatory Best Practices Committee, made up of co-chairs, more than 30 experts, and patient advocates, released draft guidance for public comment, and extended the comment period to December 15 so more voices could weigh in. The draft prompted two Members of the European Parliament to write to the European Medicines Agency, and on November 4 one of them convened a panel at the European Parliament, “Expanding Male Contraceptive Options.” Speakers included the committee’s co-chair Dr. Erin Gardner, Dr. Nadja Mannowetz of YourChoice Therapeutics, and the EMA’s Chief Medical Officer. The committee plans to publish its final report in early 2026.
Policy Partnership in Europe
Working with DSW, MCI produced policy papers and briefings, engaged 21 organizations, held exchanges with European decision-makers, and secured media features.
Storytelling
MCI screened the documentary It’s Different for Girls at the National Contraception Meeting, and team members continued to share research and perspectives through monthly newsletters and webinars, including a regulatory recommendations webinar and a Founder Playbook launch in September.
MCI’s Outreach & Advocacy Strategy
Donor Highlight
Male contraceptive research faces a persistent shortfall in financial support—a systemic oversight that severely restricts breakthroughs despite its capacity to address vital global needs. Because of this resource deficit, transformative concepts stall, delaying true reproductive freedom.
Amid these constraints, Male Contraceptive Initiative serves as a crucial catalyst for meaningful change. Notably, although MCI stands among the top six global financial contributors to reproductive control research across all demographics, our yearly allocation totals under $2 million. This reality highlights our strategic efficiency while demonstrating the extraordinary progress that substantial additional investment would generate. Ultimately, the entire sector requires a major capital influx; until then, donor generosity directly sustains every advance.
MCI remains steadfast in backing scientists developing novel male methods, guiding them from initial discovery toward commercial availability. As a nonprofit entity, each research milestone and clinical trial depends entirely on dedicated philanthropic partners who share our commitment. Every contribution directly accelerates the delivery of expanded reproductive choices worldwide.
Our foundational progress in 2025 was propelled by the generous support of our partner network. We express sincere gratitude to the contributors whose dedication fueled our ongoing mission.
MCI's Staff & Board
Male Contraceptive Initiative’s strength lies in its people. Our staff, esteemed board members, and insightful advisors form a holistic and purpose-driven ecosystem of stakeholders, each passionately committed to advancing the field of male contraception. This intentional convergence of leaders from science, medicine, communications, advocacy, and community engagement ensures a well-rounded strategic direction.
Our dedicated staff members are the engine of our progress. They embody a rich mosaic of backgrounds, skills, and experiences, contributing to a dynamic and inclusive organizational culture. We believe that the diversity of our team—in thought, experience, and identity—is fundamental to dissecting the complex challenges and seizing the transformative opportunities inherent in male contraception. This inclusive approach empowers us to develop more creative and effective strategies, ensuring that every step we take brings us closer to realizing ‘Reproductive Autonomy for All.’
Connect & Collaborate: Let's Advance Male Contraception Together
Your voice, insights, and support are crucial to our mission. At Male Contraceptive Initiative, we firmly believe that our collective impact will always exponentially exceed what any one of us can achieve alone. We are eager to hear from individuals and organizations passionate about revolutionizing family planning.
Whether you have questions, ideas for collaboration, wish to explore partnership opportunities, or want to learn more about how you can contribute to this vital work, please don’t hesitate to reach out. Let’s discuss how we can join forces to move the field of male contraception decisively forward.
811 Ninth Street, Suite 120 #255
Durham, NC 27705
contact@malecontraceptive.org